Robert P Lanza

This inventor holds 59 USPTO granted patents and 44 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Stem Cell Technology (CPC class C12N). Top assignees: Astellas Institute for Regenerative Medicine, Advanced Cell Technology, Inc., Ocata Therapeutics, Inc.. Active years: 1997-2026.

USPTO Granted Patents = 59 (Patent Applications = 44)

% Patents Active = 98.3

CIPO Patents = 1 (Patent Applications = 11)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 2.5

ph-index = 17

Forward Citations = 752(Granted Patents)

Forward Citations (Not Self Cited) = 522(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Natick, MA (US) (1997 - 1999)
Clinton, MA (US) (1999 - 2024)

Company Filing History:

29 out of 40

Astellas Institute for Regenerative Medicine

patents

12 out of 21

Advanced Cell Technology, Inc.

patents

10 out of 10

Ocata Therapeutics, Inc.

patents

4. 5 out of 5

Biohybrid Technologies LLC

patents

5. 1 out of 1

Advance Cell Technology, Inc.

patent

6. 1 out of 1

Biohybrio Technologies LLC

Years Active: 1997-2026

Loading Chart...

Areas of Expertise:

Pluripotent Stem Cells

Photoreceptors

Mesenchymal Stromal Cells

Retinal Pigment Epithelium

Hemogenic Endothelial Cells

Corneal Endothelial Cells

Degenerative Diseases

Embryonic Stem Cells

Erythroid Cells

Blastomere Culture

Colony Forming Cells

Differentiation Methods

59 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE50977 - METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF (2026-08-04),

2. RE50916 - METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF (2026-06-16),

3. 12653840 - METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF (2026-06-16),

4. 12558380 - Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells (2026-02-24),

5. 12508284 - Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells (2025-12-30),

6. 12465621 - Mesenchymal stromal cells and uses related thereto (2025-11-11),

7. 12209255 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2025-01-28),

8. 12109239 - Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof (2024-10-08),

9. 12097223 - Mesenchymal stromal cells and uses related thereto (2024-09-24),

10. 12076347 - Methods for production of platelets from pluripotent stem cells and compositions thereof (2024-09-03),

11. 12049642 - Corneal endothelial cells with increased cell density and compositions thereof (2024-07-30),

12. 11566228 - Hemangio-colony forming cells (2023-01-31),

13. 11400118 - Methods for production of platelets from pluripotent stem cells and compositions thereof (2022-08-02),

14. 11241460 - Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells (2022-02-08),

15. 10894065 - Methods for production of platelets from pluripotent stem cells and compositions thereof (2021-01-19),

Title: The Innovative Mind of Robert P Lanza

Introduction: Robert P Lanza is a renowned inventor hailing from Clinton, MA (US). His groundbreaking work has significantly impacted the field of innovation and patents.

Latest Patents: Robert P Lanza holds several patents in various industries, showcasing his diverse range of expertise and creativity.

Career Highlights: Throughout his illustrious career, Robert P Lanza has consistently pushed the boundaries of traditional thinking, leading to the development of revolutionary inventions that have changed the landscape of modern technology.

Collaborations: Robert P Lanza has collaborated with leading companies, universities, and research institutions, further solidifying his reputation as a visionary inventor with a keen eye for cutting-edge solutions.

Conclusion: In conclusion, Robert P Lanza's contributions to the world of inventions and patents are truly remarkable, and his legacy will continue to inspire future generations of innovators.